Global Bioinformatics Market to Hit USD 46.42 Bn by 2035 | CAGR 12.7%

Read more about this report- Global Bioinformatics Market to Hit USD 46.42 Bn by 2035 | CAGR 12.7%

The Bioinformatics Market is valued at USD 12.46 Billion in 2024. The Bioinformatics Market will achieve USD 46.42 Billion by 2035 through a projected 12.7% CAGR from 2025 to 2035.

The driving force behind the development of precision medicine is simple: there is an exponential increase in the amount of genomic data, and the high-throughput sequencing technologies encourage its creation. Data privacy issues and non-standardised data formats, however, are significant limiting factors to the smooth integration and scalability of bioinformatics. With the emergence of AI and machine learning in life sciences, a significant opportunity in predictive analytics and superior biological solutions emerges that will lead to personalised models of healthcare.

The bioinformatics industry is divided into platforms, tools, and services by type; genomics, proteomics, transcriptomics, metabolomics, and others by application; knowledge management tools, bioinformatics platforms, and bioinformatics services by technology; and academic institutes, pharmaceutical and biotech companies, hospitals, and research centres by end-user. Genomics is leading the application segment, as next-generation sequencing (NGS) and cost-effective whole-genome analysis are being widely used, especially in disease gene discovery and drug target discovery.

Examples of use cases are drug discovery, disease diagnostics, environmental monitoring, agricultural biotechnology, and forensic science. The field of drug discovery is also rapidly shifting towards AI-based algorithms and cloud-based target identification platforms that simplify preclinical research and reduce the time spent on R&D. The increased use of bioinformatics in drug research and development and the emergence of AI-driven bioinformatics tools are changing the way new therapeutics are being developed. The National Institutes of Health (NIH) in the U.S. has also increased its funding of large-scale data repositories such as All of Us and has enhanced access to data by researchers and facilitated the use of bioinformatics in population health programmes.

The bioinformatics industry is supported by five geographic regions: North America, Europe, Asia Pacific, Latin America and the Middle East, and Africa. China is an exceptional country in the Asia-Pacific, with enormous investment in genomics infrastructure and national data initiatives, enhanced by government programmes like the China Precision Medicine Initiative that encourage large-scale sequencing projects as well as sophisticated bioinformatics systems.

The major players in the bioinformatics industry are Thermo Fisher Scientific, Illumina, Qiagen, BGI Group, and Agilent Technologies. The market is being shaped by these companies through the addition of product lines in sequencing software and cloud-based applications, international partnerships, and the development of algorithmic instruments to tackle challenging biological data.